Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030

Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030


The Autologous Stem Cell & Non-Stem Cell Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market, highlighting leading vendors and their innovative profiles. These include Brainstorm Cell Therapeutics, Inc., Castle Creek Biosciences Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences, Inc., HCA International Limited, Hemogenyx Pharmaceuticals PLC, Hemostemix Inc., Jasper Therapeutics, Inc., NOVADIP Biosciences S.A., Novartis AG, Opexa Therapeutics, Inc., Regeneus Ltd., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Autologous Stem Cell & Non-Stem Cell Based Therapies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Autologous Non-Stem Cells
  • Autologous Stem Cells
  • Indication

    Cancer
  • Cardiovascular Disease
  • Neurodegenerative Disorders
  • Orthopedic Diseases
  • End-User

    Ambulatory Surgical Centers
  • Hospitals
  • Research Facilities
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
    3. What are the technology trends and regulatory frameworks in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
    4. What is the market share of the leading vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
    5. Which modes and strategic moves are suitable for entering the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?


    Note: PDF & Excel + Online Access - 1 Year

  • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rise in the prevalence of cancer and diabetes among population
    5.1.1.2. Increased demand to manage a large number of infectious diseases
    5.1.1.3. Advantage of intensive therapy for older patients
    5.1.2. Restraints
    5.1.2.1. High costs associated with autologous stem cell & non-stem cell therapies
    5.1.3. Opportunities
    5.1.3.1. Rise in investment for extensive research and development
    5.1.3.2. Advances in treating various diseases, neurodegenerative diseases and macular degeneration
    5.1.4. Challenges
    5.1.4.1. Risks and complications associated with the therapy
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Type
    6.1. Introduction
    6.2. Autologous Non-Stem Cells
    6.3. Autologous Stem Cells
    7. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Indication
    7.1. Introduction
    7.2. Cancer
    7.3. Cardiovascular Disease
    7.4. Neurodegenerative Disorders
    7.5. Orthopedic Diseases
    8. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by End-User
    8.1. Introduction
    8.2. Ambulatory Surgical Centers
    8.3. Hospitals
    8.4. Research Facilities
    9. Americas Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. Brainstorm Cell Therapeutics, Inc.
    13.1.2. Castle Creek Biosciences Inc.
    13.1.3. Cytori Therapeutics Inc.
    13.1.4. Dendreon Pharmaceuticals LLC
    13.1.5. Gilead Sciences, Inc.
    13.1.6. HCA International Limited
    13.1.7. Hemogenyx Pharmaceuticals PLC
    13.1.8. Hemostemix Inc.
    13.1.9. Jasper Therapeutics, Inc.
    13.1.10. NOVADIP Biosciences S.A.
    13.1.11. Novartis AG
    13.1.12. Opexa Therapeutics, Inc.
    13.1.13. Regeneus Ltd.
    13.1.14. Takeda Pharmaceutical Company Limited
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET RESEARCH PROCESS
    FIGURE 2. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2023 VS 2030
    FIGURE 3. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET DYNAMICS
    FIGURE 7. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 8. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
    FIGURE 10. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 12. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2023

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings